Our Research

Please use selectors to filter reports

May 24, 2024
Unlisted Managed Investment

Neuberger Berman Global High Yield Fund Update

IIR has provided an update report for Neuberger Berman Global High Yield Fund, formerly NB Global Corporate Income Trust....
Request professional access
May 21, 2024
Equity Research Coverage
U.S. Equities

Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Update

We have completed an update report for Acurx following the release of the March quarterly report on 14 May 2024 and the business update provided on 15 May 2024....
Request professional access
May 10, 2024
Listed Managed Investment

Gryphon Capital Income Trust (ASX: GCI) Review

Gryphon Capital Income Trust (ASX: GCI) is a listed investment trust (LIT) designed to provide investors with regular monthly income through an actively managed portfolio of Residential Mortgage Backed Securities (RMBS) and Asset Backed Securities (A...
Request professional access
May 9, 2024
Newsletters
Newsletters & Thematics

Movers & Shakers – Pharma & Biotech

In this edition of the Movers & Shakers for Pharma & Biotech we take a look at four companies whose share prices rallied during the month....
Request professional access
May 7, 2024
Listed Managed Investment
Newsletters
Newsletters & Thematics

LMI Monthly Update

In this edition of the LMI Monthly Update we take a look at the key news items in April as well as provide key data points as at 31 March 2024. ...
Request professional access
May 6, 2024
Company Profile Reporting

Updated Coverage of Revolver Resources (ASX: RRR)

Revolver Resources Ltd (ASX: RRR) is actively and effectively exploring two highly prospective projects in North Queensland - the 874 km2 Dianne Project, over and around the historically-operated Dianne Copper Mine in the Paleozoic Hodgkinson Basin, ...
Request professional access
April 15, 2024
Listed Managed Investment

Qualitas Real Estate Income Fund (ASX: QRI) Review

IIR has completed a review of Qualitas Real Estate Income Fund (ASX: QRI)....
Request professional access
April 8, 2024
Newsletters
Newsletters & Thematics

Movers & Shakers: Pharma & Biotech – 8 April 2024

The Pharma and Biotech market was relatively buoyant in March with 49% of share prices in the coverage universe increasing for the month. There was some significant news flow which resulted in a strong uplift in share prices for some companies........
Request professional access
April 4, 2024
Listed Managed Investment
Newsletters
Newsletters & Thematics

LMI Monthly Update – 3 April 2024

This edition of the monthly update looks at the key newsflow and observations from March 2024 as well as the key data points as at 29 February 2024. ...
Request professional access